$SCYX
SCYNEXIS INC Stock $scyx

$scyx Overview Financials Valuation SEC Filings Company Website

2015 Q4 Form 10-Q Financial Statement

#000117825315000130 Filed on November 13, 2015

Income Statement

Concept	2015 Q4	2015 Q3	2014 Q3
Revenue	$64.00K	$64.00K	$61.00K
YoY Change	-93.96%	4.92%	-98.53%
Cost Of Revenue			$3.660M
YoY Change			-8.18%
Gross Profit			$720.0K
YoY Change			306.78%
Gross Profit Margin			1180.33%
Selling, General & Admin	$2.540M	$4.143M	$2.121M
YoY Change	25.12%	95.33%	85.89%
% of Gross Profit			294.58%
Research & Development	$5.920M	$3.458M	$2.478M
YoY Change	121.72%	39.55%	136.0%
% of Gross Profit			344.17%
Depreciation & Amortization	$0.00	$0.00	$303.0K
YoY Change	-100.0%	-100.0%	-5.61%
% of Gross Profit			42.08%
Operating Expenses	$8.450M	$7.601M	$4.599M
YoY Change	79.79%	65.28%	110.1%
Operating Profit	-$8.387M	-$7.537M	-$4.538M
YoY Change		66.09%	125.55%
Interest Expense	$0.00	$8.000K	$0.00
YoY Change			-100.0%
% of Operating Profit
Other Income/Expense, Net	$0.00	$8.000K	$0.00
YoY Change			-100.0%
Pretax Income	-$8.390M	-$7.529M	-$4.538M
YoY Change	130.49%	65.91%	14.6%
Income Tax	$0.00	$0.00	-$338.0K
% Of Pretax Income
Net Earnings	-$8.387M	-$8.355M	-$3.804M
YoY Change	172.31%	119.64%	-3.94%
Net Earnings / Revenue	-13104.69%	-13054.69%	-6236.07%
Basic Earnings Per Share		-$0.60	-$0.45
Diluted Earnings Per Share	-$6.036M	-$0.60	-$0.45
COMMON SHARES
Basic Shares Outstanding	13.91M shares	13.90M shares	8.505M shares
Diluted Shares Outstanding		13.90M shares	8.505M shares

Balance Sheet

Concept	2015 Q4	2015 Q3	2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$47.00M	$53.80M	$34.00M
YoY Change	45.96%	58.24%
Cash & Equivalents	$46.99M	$53.77M	$34.04M
Short-Term Investments
Other Short-Term Assets	$38.00K	$872.0K	$1.800M
YoY Change	1166.67%	-51.56%
Inventory
Prepaid Expenses
Receivables			$999.0K
Other Receivables			$0.00
Total Short-Term Assets	$48.44M	$55.92M	$36.80M
YoY Change	22.17%	51.97%
LONG-TERM ASSETS
Property, Plant & Equipment	$42.00K		$5.060M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$419.0K	$86.00K	$106.0K
YoY Change	1576.0%	-18.87%
Total Long-Term Assets	$836.0K	$172.0K	$5.166M
YoY Change	3244.0%	-96.67%
TOTAL ASSETS
Total Short-Term Assets	$48.44M	$55.92M	$36.80M
Total Long-Term Assets	$836.0K	$172.0K	$5.166M
Total Assets	$49.27M	$56.10M	$41.96M
YoY Change	24.2%	33.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$619.0K	$796.0K	$640.0K
YoY Change	45.31%	24.38%
Accrued Expenses	$3.149M	$1.539M	$2.021M
YoY Change	40.27%	-23.85%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due			$0.00
YoY Change
Total Short-Term Liabilities	$6.664M	$5.393M	$3.197M
YoY Change	24.61%	68.69%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$700.0K	$700.0K	$2.600M
YoY Change	-22.22%	-73.08%
Total Long-Term Liabilities	$0.00	$700.0K	$2.600M
YoY Change	-100.0%	-73.08%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.664M	$5.393M	$3.197M
Total Long-Term Liabilities	$0.00	$700.0K	$2.600M
Total Liabilities	$7.324M	$6.125M	$5.822M
YoY Change	17.35%	5.2%
SHAREHOLDERS EQUITY
Retained Earnings	-$150.1M	-$141.7M	-$114.4M
YoY Change	27.76%	23.86%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$41.95M	$49.97M	$36.14M
YoY Change
Total Liabilities & Shareholders Equity	$49.27M	$56.10M	$41.96M
YoY Change	24.2%	33.67%

Cashflow Statement

Concept	2015 Q4	2015 Q3	2014 Q3
OPERATING ACTIVITIES
Net Income	-$8.387M	-$8.355M	-$3.804M
YoY Change	172.31%	119.64%	-3.94%
Depreciation, Depletion And Amortization	$0.00	$0.00	$303.0K
YoY Change	-100.0%	-100.0%	-5.61%
Cash From Operating Activities	-$5.990M	-$5.740M	-$3.680M
YoY Change	248.26%	55.98%	2353.33%
INVESTING ACTIVITIES
Capital Expenditures	-$40.00K	-$20.00K	-$310.0K
YoY Change	-42.86%	-93.55%	416.67%
Acquisitions
YoY Change
Other Investing Activities	-$370.0K	$2.550M	$0.00
YoY Change
Cash From Investing Activities	-$410.0K	$2.530M	-$310.0K
YoY Change	485.71%	-916.13%	520.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-380.0K	-80.00K	-400.0K
YoY Change		-80.0%	-253.85%
NET CHANGE
Cash From Operating Activities	-5.990M	-5.740M	-3.680M
Cash From Investing Activities	-410.0K	2.530M	-310.0K
Cash From Financing Activities	-380.0K	-80.00K	-400.0K
Net Change In Cash	-6.780M	-3.290M	-4.390M
YoY Change	278.77%	-25.06%	-7416.67%
FREE CASH FLOW
Cash From Operating Activities	-$5.990M	-$5.740M	-$3.680M
Capital Expenditures	-$40.00K	-$20.00K	-$310.0K
Free Cash Flow	-$5.950M	-$5.720M	-$3.370M
YoY Change	260.61%	69.73%	3644.44%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	dei	Document Period End Date DocumentPeriodEndDate	2015-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001178253
CY2015Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	13905599	shares
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	1999-11-04
	dei	Entity Registrant Name EntityRegistrantName	SCYNEXIS INC
CY2014Q4	scyx	Accrued Severanceand Retention Costs Current AccruedSeveranceandRetentionCostsCurrent	0	USD
CY2015Q3	scyx	Accrued Severanceand Retention Costs Current AccruedSeveranceandRetentionCostsCurrent	2801000	USD
CY2014Q4	scyx	Accrued Severanceand Retention Costs Noncurrent AccruedSeveranceandRetentionCostsNoncurrent	0	USD
CY2015Q3	scyx	Accrued Severanceand Retention Costs Noncurrent AccruedSeveranceandRetentionCostsNoncurrent	8000	USD
CY2015Q3	scyx	Additional Milestone Payments Maximum AdditionalMilestonePaymentsMaximum	2300000	USD
CY2014Q2	scyx	Adjustmentto Additional Paidin Capital Reclassificationof Warrant Derivative Liability AdjustmenttoAdditionalPaidinCapitalReclassificationofWarrantDerivativeLiability	2701000	USD
CY2014Q3	scyx	Deemed Dividend Associated With Beneficial Conversion Of Convertible Preferred Stock DeemedDividendAssociatedWithBeneficialConversionOfConvertiblePreferredStock	0	USD
	scyx	Deemed Dividend Associated With Beneficial Conversion Of Convertible Preferred Stock DeemedDividendAssociatedWithBeneficialConversionOfConvertiblePreferredStock	909000	USD
CY2015Q3	scyx	Deemed Dividend Associated With Beneficial Conversion Of Convertible Preferred Stock DeemedDividendAssociatedWithBeneficialConversionOfConvertiblePreferredStock	0	USD
	scyx	Deemed Dividend Associated With Beneficial Conversion Of Convertible Preferred Stock DeemedDividendAssociatedWithBeneficialConversionOfConvertiblePreferredStock	0	USD
CY2014Q3	scyx	Deemed Dividend For Antidilution Adjustments To Convertible Preferred Stock DeemedDividendForAntidilutionAdjustmentsToConvertiblePreferredStock	0	USD
	scyx	Deemed Dividend For Antidilution Adjustments To Convertible Preferred Stock DeemedDividendForAntidilutionAdjustmentsToConvertiblePreferredStock	214000	USD
CY2015Q3	scyx	Deemed Dividend For Antidilution Adjustments To Convertible Preferred Stock DeemedDividendForAntidilutionAdjustmentsToConvertiblePreferredStock	0	USD
	scyx	Deemed Dividend For Antidilution Adjustments To Convertible Preferred Stock DeemedDividendForAntidilutionAdjustmentsToConvertiblePreferredStock	0	USD
	scyx	Deferred Offering Costs Incurred But Not Yet Paid DeferredOfferingCostsIncurredButNotYetPaid	0	USD
	scyx	Deferred Offering Costs Incurred But Not Yet Paid DeferredOfferingCostsIncurredButNotYetPaid	52000	USD
	scyx	Property And Equipment Purchases In Accounts Payable PropertyAndEquipmentPurchasesInAccountsPayable	11000	USD
	scyx	Deferred Offering Costs Reclassified To Additional Paid In Capital DeferredOfferingCostsReclassifiedToAdditionalPaidInCapital	4127000	USD
	scyx	Deferred Offering Costs Reclassified To Additional Paid In Capital DeferredOfferingCostsReclassifiedToAdditionalPaidInCapital	3388000	USD
CY2013Q3	scyx	Deferred Revenue Recognition Period DeferredRevenueRecognitionPeriod	P70M
	scyx	Derivative Fair Value Gain Loss From Mark To Market Adjustment DerivativeFairValueGainLossFromMarkToMarketAdjustment	10442000	USD
	scyx	Excess Of Fair Value Warrants Over Proceeds ExcessOfFairValueWarrantsOverProceeds	362000	USD
CY2014Q2	scyx	Issuance Of Common Stock Pursuant To Conversion Of Warrants Shares IssuanceOfCommonStockPursuantToConversionOfWarrantsShares	275687	shares
CY2015Q3	scyx	Monthly License Fee MonthlyLicenseFee	8000	USD
CY2015Q3	scyx	Number Of License Agreements NumberOfLicenseAgreements	2	Agreement
CY2014Q2	scyx	Offering Expenses OfferingExpenses	4127000	USD
CY2015Q2	scyx	Proceedsfrom Issuanceof Common Stock Netof Issuance Costs ProceedsfromIssuanceofCommonStockNetofIssuanceCosts	38012000	USD
CY2014Q3	scyx	Income Lossfrom Continuing Operations Attributableto Parent Basic IncomeLossfromContinuingOperationsAttributabletoParentBasic	-4200000	USD
	scyx	Income Lossfrom Continuing Operations Attributableto Parent Basic IncomeLossfromContinuingOperationsAttributabletoParentBasic	-3858000	USD
CY2015Q3	scyx	Income Lossfrom Continuing Operations Attributableto Parent Basic IncomeLossfromContinuingOperationsAttributabletoParentBasic	-7529000	USD
	scyx	Income Lossfrom Continuing Operations Attributableto Parent Basic IncomeLossfromContinuingOperationsAttributabletoParentBasic	-19950000	USD
CY2014Q3	scyx	Income Lossfrom Continuing Operations Attributableto Parent Diluted IncomeLossfromContinuingOperationsAttributabletoParentDiluted	-4200000	USD
	scyx	Income Lossfrom Continuing Operations Attributableto Parent Diluted IncomeLossfromContinuingOperationsAttributabletoParentDiluted	-13938000	USD
CY2015Q3	scyx	Income Lossfrom Continuing Operations Attributableto Parent Diluted IncomeLossfromContinuingOperationsAttributabletoParentDiluted	-7529000	USD
	scyx	Income Lossfrom Continuing Operations Attributableto Parent Diluted IncomeLossfromContinuingOperationsAttributabletoParentDiluted	-19950000	USD
	scyx	Increase Decrease In Deferred Rent IncreaseDecreaseInDeferredRent	-97000	USD
	scyx	Increase Decrease In Deferred Rent IncreaseDecreaseInDeferredRent	-108000	USD
CY2014Q1	scyx	Ipo Gross Proceeds Threshold That Triggers Automatic Conversion Of Preferred Stock IpoGrossProceedsThresholdThatTriggersAutomaticConversionOfPreferredStock	20000000	USD
CY2014Q2	scyx	Issuance Of Common Stock Pursuant To Conversion Of Warrants Shares IssuanceOfCommonStockPursuantToConversionOfWarrantsShares	275687	shares
	scyx	Property And Equipment Purchases In Accounts Payable PropertyAndEquipmentPurchasesInAccountsPayable	12000	USD
CY2014Q3	scyx	Researchand Development Expense Gross ResearchandDevelopmentExpenseGross	2478000	USD
	scyx	Researchand Development Expense Gross ResearchandDevelopmentExpenseGross	5621000	USD
CY2015Q3	scyx	Researchand Development Expense Gross ResearchandDevelopmentExpenseGross	3553000	USD
	scyx	Researchand Development Expense Gross ResearchandDevelopmentExpenseGross	11352000	USD
CY2014Q3	scyx	Researchand Development Income Reimbursement ResearchandDevelopmentIncomeReimbursement	0	USD
	scyx	Researchand Development Income Reimbursement ResearchandDevelopmentIncomeReimbursement	0	USD
CY2015Q3	scyx	Researchand Development Income Reimbursement ResearchandDevelopmentIncomeReimbursement	95000	USD
	scyx	Researchand Development Income Reimbursement ResearchandDevelopmentIncomeReimbursement	827000	USD
	scyx	Warrant Derivative Liability Reclassified To Additional Paid In Capital WarrantDerivativeLiabilityReclassifiedToAdditionalPaidInCapital	2701000	USD
	scyx	Warrant Derivative Liability Reclassified To Additional Paid In Capital WarrantDerivativeLiabilityReclassifiedToAdditionalPaidInCapital	0	USD
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	426000	USD
CY2015Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	796000	USD
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2245000	USD
CY2015Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1539000	USD
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	150934000	USD
CY2015Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	191702000	USD
CY2014Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	455000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	837000	USD
CY2015Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1541000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2656000	USD
	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	75000	USD
	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	0	USD
CY2015Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	847711	shares
CY2014Q3	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	755000	USD
CY2015Q3	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	51000	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2014Q4	us-gaap	Assets Assets	39672000	USD
CY2015Q3	us-gaap	Assets Assets	56095000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	39647000	USD
CY2015Q3	us-gaap	Assets Current AssetsCurrent	55923000	USD
CY2014Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	6701000	USD
CY2015Q3	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1402000	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	34036000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	32243000	USD
CY2015Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	53766000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	32634000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	21523000	USD
CY2014Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.20
CY2014Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	14033	shares
CY2015Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	14033	shares
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	2161458	shares
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2015Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8512103	shares
CY2015Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13905599	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8512103	shares
CY2015Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13905599	shares
CY2014Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	8000	USD
CY2015Q3	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	14000	USD
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	88790000	USD
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	USD
CY2015Q2	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	1691884	shares
CY2014Q2	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	1691884	shares
CY2014Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	0	USD
CY2015Q3	us-gaap	Deferred Offering Costs DeferredOfferingCosts	86000	USD
CY2014Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	0	USD
CY2015Q3	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	25000	USD
CY2014Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	257000	USD
CY2015Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	257000	USD
CY2014Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	893000	USD
CY2015Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	699000	USD
	us-gaap	Depreciation Depreciation	918000	USD
	us-gaap	Depreciation Depreciation	447000	USD
CY2013Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	12200000	USD
CY2014Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	9998000	USD
CY2014Q3	us-gaap	Dilutive Securities DilutiveSecurities	0	USD
	us-gaap	Dilutive Securities DilutiveSecurities	-10080000	USD
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.60
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.09
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.45
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.59
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.60
CY2015Q3	us-gaap	Dilutive Securities DilutiveSecurities	0	USD
	us-gaap	Dilutive Securities DilutiveSecurities	0	USD
CY2014Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	0.05
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	0.23
CY2015Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-0.06
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-0.37
CY2014Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	0.05
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	0.21
CY2015Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	-0.06
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	-0.37
CY2014Q3	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	338000	USD
	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	909000	USD
CY2015Q3	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	0	USD
	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	0	USD
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.45
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.59
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.09
CY2014Q3	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	USD
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	USD
CY2015Q3	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	USD
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	USD
CY2014Q2	us-gaap	Expense Related To Distribution Or Servicing And Underwriting Fees ExpenseRelatedToDistributionOrServicingAndUnderwritingFees	3290000	USD
CY2014Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-10080000	USD
CY2015Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	544000	USD
CY2013Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	12237000	USD
CY2014Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	0	USD
	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	USD
CY2015Q3	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-73000	USD
	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-73000	USD
CY2014Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1389000	USD
CY2015Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	USD
	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	586000	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-4200000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-2225000	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-7529000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-19950000	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-4538000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-3134000	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-7529000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-19950000	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.50
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.82
CY2015Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.54
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.72
CY2014Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.50
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-2.80
CY2015Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.54
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-1.72
CY2014Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	396000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	1066000	USD
CY2015Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-826000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-4285000	USD
CY2014Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-338000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-909000	USD
CY2015Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	907000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-431000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	252000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	523000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	147000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1018000	USD
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	876000	USD
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	855000	USD
	us-gaap	Increase Decrease In Restructuring Reserve IncreaseDecreaseInRestructuringReserve	0	USD
	us-gaap	Increase Decrease In Restructuring Reserve IncreaseDecreaseInRestructuringReserve	2809000	USD
CY2014Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	273687	shares
CY2015Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Insured Event Gain Loss InsuredEventGainLoss	165000	USD
	us-gaap	Insured Event Gain Loss InsuredEventGainLoss	0	USD
CY2014Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	0	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-49000	USD
CY2015Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	8000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	10000	USD
	us-gaap	Interest Paid InterestPaid	49000	USD
	us-gaap	Interest Paid InterestPaid	0	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2792000	USD
CY2014Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	235000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	702000	USD
CY2015Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	86000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	522000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	6241000	USD
CY2015Q3	us-gaap	Liabilities Liabilities	6125000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	39672000	USD
CY2015Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	56095000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5348000	USD
CY2015Q3	us-gaap	Liabilities Current LiabilitiesCurrent	5393000	USD
CY2014Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	2420000	USD
CY2015Q3	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	USD
CY2014Q3	us-gaap	License And Services Revenue LicenseAndServicesRevenue	61000	USD
	us-gaap	License And Services Revenue LicenseAndServicesRevenue	192000	USD
CY2015Q3	us-gaap	License And Services Revenue LicenseAndServicesRevenue	64000	USD
	us-gaap	License And Services Revenue LicenseAndServicesRevenue	193000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	40801000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	38084000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-416000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2002000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7751000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-18563000	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	-3804000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-1159000	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	-8355000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-24235000	USD
CY2014Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3804000	USD
CY2015Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8355000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-24235000	USD
CY2014Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-3804000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-12872000	USD
CY2015Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-8355000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-24235000	USD
CY2014Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	0	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	7877000	USD
CY2015Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	8000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	10000	USD
CY2014Q3	us-gaap	Operating Expenses OperatingExpenses	4599000	USD
	us-gaap	Operating Expenses OperatingExpenses	11203000	USD
CY2015Q3	us-gaap	Operating Expenses OperatingExpenses	7601000	USD
	us-gaap	Operating Expenses OperatingExpenses	20153000	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-4538000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-11011000	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-7537000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-19960000	USD
CY2015Q3	us-gaap	Other Assets Current OtherAssetsCurrent	872000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	25000	USD
CY2015Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	86000	USD
CY2015Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2157000	USD
	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	216000	USD
	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	0	USD
CY2014Q2	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	54583000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	62000000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	41400000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	884000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	0	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	182000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	307000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	298000	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	0	USD
CY2015Q3	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	97000	USD
CY2014Q4	us-gaap	Other Assets Current OtherAssetsCurrent	226000	USD
CY2014Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-10000	USD
CY2015Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	6875000	USD
	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	3422000	USD
CY2015Q2	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	3388000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	632000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	547000	USD
CY2014Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	USD
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	1633000	USD
CY2015Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	USD
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	0	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	703000	USD
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	544000	USD
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	68000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	106000	USD
CY2013Q3	us-gaap	Proceeds From License Fees Received ProceedsFromLicenseFeesReceived	1500000	USD
	us-gaap	Proceeds From Royalties Received ProceedsFromRoyaltiesReceived	0	USD
	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	0	USD
	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	2549000	USD
CY2014Q3	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	9000	USD
CY2015Q3	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-117511000	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	55000	USD
	us-gaap	Profit Loss ProfitLoss	-1159000	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
	us-gaap	Profit Loss ProfitLoss	-24235000	USD
CY2014Q3	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	0	USD
	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	500000	USD
CY2015Q3	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	0	USD
	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	0	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	15000000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2014Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2478000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5621000	USD
CY2015Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3458000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10525000	USD
CY2015Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-141746000	USD
CY2014Q3	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	1822000	USD
	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	5466000	USD
CY2015Q3	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	165000	USD
	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	2140000	USD
CY2014Q3	us-gaap	Revenues Revenues	61000	USD
	us-gaap	Revenues Revenues	192000	USD
CY2015Q3	us-gaap	Revenues Revenues	64000	USD
	us-gaap	Revenues Revenues	193000	USD
CY2014Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2121000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5582000	USD
CY2015Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4143000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9628000	USD
CY2014Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	615322	shares
CY2015Q3	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	1207697	shares
CY2014Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	10.00
CY2015Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	7.7000
CY2015Q1	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	15107	shares
CY2015Q3	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	1767	shares
	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	16874	shares
CY2014Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	6200000	shares
CY2015Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	5376622	shares
	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	5376622	shares
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	33431000	USD
CY2015Q3	us-gaap	Stockholders Equity StockholdersEquity	49970000	USD
CY2014Q1	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.25
CY2014Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-4 reverse stock split
	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	510000	USD
	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	0	USD
CY2014Q3	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	0	USD
	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	510000	USD
CY2015Q3	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	0	USD
	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	0	USD
CY2014Q3	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	USD
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	USD
CY2015Q3	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	USD
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	USD
CY2014Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8504785	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4976965	shares
CY2015Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13904331	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11576498	shares
CY2014Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8504785	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4703278	shares
CY2015Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13904331	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11576498	shares
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;padding-left:0px;text-indent:30px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-style:italic;font-weight:normal;text-decoration:none;">Concentration of Credit Risk</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">Financial instruments, which potentially expose the Company to concentrations of credit risk consist principally of cash on deposit with a bank, which exceeds the FDIC insurance limits, as well as accounts receivable and unbilled services. Ongoing credit evaluations of the bank and customers' financial condition and independent ratings are reviewed by the Company. Collateralization of deposits has not been required. </font></div></div>
	us-gaap	Revenue Recognition Deferred Revenue RevenueRecognitionDeferredRevenue	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;padding-left:0px;text-indent:30px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;font-style:italic;font-weight:normal;text-decoration:none;">Revenue Recognition and Deferred Revenue</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">The Company historically derived the majority of its revenue from providing contract research and development services under fee for service arrangements, which were provided by the Company's Services Business that was sold in July 2015 (see Notes 1 and 13). The Company also has entered into collaboration arrangements in exchange for non-refundable upfront payments and consideration as services are performed. These arrangements include multiple elements, such as the sale of licenses and the provision of services. Under these arrangements, the Company also is entitled to receive development milestone payments and royalties in the form of a designated percentage of product sales. The Company classifies non-refundable upfront payments, milestone payments and royalties received under collaboration and licensing agreements as revenues within its statements of operations because the Company views such activities as being central to its business operations.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">Revenue is recognized when all of the following conditions are met: (i) persuasive evidence of an arrangement exists, (ii) delivery has occurred or services have been rendered, (iii) fees are fixed or determinable, and (iv) collection of fees is reasonably assured. The Company’s contract research and development services revenue was recognized in the period in which the services were performed. </font></div><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">When entering into an arrangement, the Company first determines whether the arrangement includes multiple deliverables and is subject to accounting guidance in ASC subtopic 605-25, </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:italic;">Multiple-Element Arrangements</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">. If the Company determines that an arrangement includes multiple elements, it determines whether the arrangement should be divided into separate units of accounting and how the arrangement consideration should be measured and allocated among the separate units of accounting. An element qualifies as a separate unit of accounting when the delivered element has standalone value to the customer. The Company’s arrangements do not include a general right of return relative to delivered elements. Any delivered elements that do not qualify as separate units of accounting are combined with other undelivered elements within the arrangement as a single unit of accounting. If the arrangement constitutes a single combined unit of accounting, the Company determines the revenue recognition method for the combined unit of accounting and recognizes the revenue over the period from inception through the date the last deliverable within the single unit of accounting is delivered.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">Non-refundable upfront license fees are recorded as deferred revenue and recognized into revenue on a straight-line basis over the estimated period of the Company’s substantive performance obligations. If the Company does not have substantive performance obligations, the Company recognizes non-refundable upfront fees into revenue through the date the deliverable is satisfied. Analyzing the arrangement to identify deliverables requires the use of judgment and each deliverable may be an obligation to deliver services, a right or license to use an asset, or another performance obligation. In arrangements that include license rights and other non-contingent deliverables, such as participation in a steering committee, these deliverables do not have standalone value because the non-contingent deliverables are dependent on the license rights. That is, the non-contingent deliverables would not have value without the license rights, and only the Company can perform the related services. Upfront license rights and non-contingent deliverables, such as participation in a steering committee, do not have standalone value as they are not sold separately and they cannot be resold. In addition, when non-contingent deliverables are sold with upfront license rights, the license rights do not represent the culmination of a separate earnings process. As such, the Company accounts for the license and the non-contingent deliverables as a single combined unit of accounting. In such instances, the license revenue in the form of non-refundable upfront payments is deferred and recognized over the applicable relationship period, which historically has been the estimated period of the Company’s substantive performance obligations or the period the rights granted are in effect. The Company recognizes contingent event-based payments under license agreements when the payments are received. The Company has not received any royalty payments to date.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">The Company will recognize a milestone payment when earned if it is substantive and the Company has </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">no</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;"> ongoing performance obligations related to the milestone. A milestone payment is considered substantive if it: 1) is commensurate with either the Company’s performance to achieve the milestone or the enhanced value of the delivered item as a result of a specific outcome from the Company’s performance to achieve the milestone; 2) relates solely to past performance; and 3) is reasonable relative to all of the deliverables and payment terms, including other potential milestone consideration, within the arrangement.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">Amounts received prior to satisfying all revenue recognition criteria are recorded as deferred revenue in the accompanying balance sheets.</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:16px;text-align:left;padding-left:0px;text-indent:36px;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;">The Company’s deferred revenue includes non-refundable upfront payments received under certain licensing and collaboration arrangements that contain substantive performance obligations that the Company is providing over respective defined service or estimated relationship periods. Such non-refundable upfront payments are recognized over these defined service or estimated relationship periods.</font></div></div>

Files In Submission

Name	View Source	Status
0001178253-15-000130-index-headers.html	Edgar Link	pending
0001178253-15-000130-index.html	Edgar Link	pending
0001178253-15-000130.txt	Edgar Link	pending
0001178253-15-000130-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
q32015exhibit101.htm	Edgar Link	pending
q32015exhibit102.htm	Edgar Link	pending
q32015exhibit106.htm	Edgar Link	pending
q32015exhibit311.htm	Edgar Link	pending
q32015exhibit312.htm	Edgar Link	pending
q32015exhibit321.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
scyx-20150930.xml	Edgar Link	completed
scyx-20150930.xsd	Edgar Link	pending
scyx-20150930x10q.htm	Edgar Link	pending
scyx-20150930_cal.xml	Edgar Link	unprocessable
scyx-20150930_def.xml	Edgar Link	unprocessable
scyx-20150930_lab.xml	Edgar Link	unprocessable
scyx-20150930_pre.xml	Edgar Link	unprocessable
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SCYX
SCYNEXIS INC Stock $scyx

2015 Q4 Form 10-Q Financial Statement

#000117825315000130 Filed on November 13, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SCYX SCYNEXIS INC Stock $scyx

2015 Q4 Form 10-Q Financial Statement

#000117825315000130 Filed on November 13, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SCYX
SCYNEXIS INC Stock $scyx